• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经白塞病患者使用英夫利昔单抗治疗 2 年成功维持缓解。

Case of neuro-Behçet's disease successfully maintained a remission using infliximab for 2 years.

机构信息

Department of Dermatology and Plastic Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.

出版信息

J Dermatol. 2013 Aug;40(8):632-4. doi: 10.1111/1346-8138.12203. Epub 2013 Jun 3.

DOI:10.1111/1346-8138.12203
PMID:23724912
Abstract

Behçet's disease is a systemic inflammatory disorder with chronic remissions and relapses. Involvement of the central nervous system, called neuro-Behçet's disease (NBD), is a serious complication. Although corticosteroids and immunosuppressive agents are used, there is no definite standard of treatment with long term-effects for NBD. Here, we report a female case with NBD successfully treated by infliximab and corticosteroids for 2 years. Our report suggests treatment with infliximab may be effective for long-term remission of NBD.

摘要

贝赫切特病是一种全身炎症性疾病,具有慢性缓解和复发的特点。中枢神经系统受累,称为神经贝赫切特病(NBD),是一种严重的并发症。尽管使用了皮质类固醇和免疫抑制剂,但 NBD 的治疗尚无长期效果的明确标准。在这里,我们报告了一例 NBD 女性病例,经英夫利昔单抗和皮质类固醇治疗 2 年成功治愈。我们的报告表明,英夫利昔单抗治疗可能对 NBD 的长期缓解有效。

相似文献

1
Case of neuro-Behçet's disease successfully maintained a remission using infliximab for 2 years.神经白塞病患者使用英夫利昔单抗治疗 2 年成功维持缓解。
J Dermatol. 2013 Aug;40(8):632-4. doi: 10.1111/1346-8138.12203. Epub 2013 Jun 3.
2
Successful treatment of long-standing neuro-Behçet's disease with infliximab.英夫利昔单抗成功治疗长期神经白塞病。
J Rheumatol. 2005 Jan;32(1):181-3.
3
Remission of Behcet's disease with anti-tumor necrosis factor monoclonal antibody therapy: a case report.抗肿瘤坏死因子单克隆抗体治疗白塞病缓解:一例报告
BMC Musculoskelet Disord. 2003 Aug 28;4:19. doi: 10.1186/1471-2474-4-19.
4
Infliximab monotherapy for neuro-Behçet's disease: a case report.英夫利昔单抗单药治疗神经白塞病:一例报告
J Neurol Sci. 2014 Dec 15;347(1-2):389-90. doi: 10.1016/j.jns.2014.09.052. Epub 2014 Oct 7.
5
Infliximab therapy in parenchymal neuro-Behçet's disease: A single-center experience.实质型神经白塞病的英夫利昔单抗治疗:单中心经验。
Int J Rheum Dis. 2021 Oct;24(10):1302-1307. doi: 10.1111/1756-185X.14209. Epub 2021 Aug 24.
6
Infliximab treatment for ocular and extraocular manifestations of Behçet's disease.英夫利昔单抗治疗白塞病的眼部和眼外表现
Jpn J Ophthalmol. 2007 May-Jun;51(3):191-6. doi: 10.1007/s10384-006-0425-y. Epub 2007 Jun 7.
7
[Behcet's refractory uveitis treated successfully by infliximab].英夫利昔单抗成功治疗白塞病难治性葡萄膜炎
Tunis Med. 2014 Jan;92(1):41-2.
8
A case of intestinal Behçet's disease treated with infliximab monotherapy who successfully maintained clinical remission and complete mucosal healing for six years.1例采用英夫利昔单抗单药治疗的肠道白塞病患者成功维持临床缓解和完全黏膜愈合达6年。
Intern Med. 2012;51(16):2125-9. doi: 10.2169/internalmedicine.51.8005. Epub 2012 Aug 15.
9
[Recent aspects of Neuro-Behcet's disease].[神经白塞病的近期研究进展]
Brain Nerve. 2013 Nov;65(11):1245-53.
10
Neuro-behçet's disease in South Korea: clinical characteristics and treatment response.韩国的神经白塞病:临床特征和治疗反应。
Int J Rheum Dis. 2014 May;17(4):453-8. doi: 10.1111/1756-185X.12265. Epub 2014 Feb 8.

引用本文的文献

1
Orbital inflammatory pseudotumor: new advances in diagnosis, pathogenesis, and treatment.眼眶炎性假瘤:在诊断、发病机制和治疗方面的新进展。
Eur J Med Res. 2023 Oct 4;28(1):395. doi: 10.1186/s40001-023-01330-0.
2
The effectiveness of the anti-tumor necrosis factor therapy infliximab in neuro-Behçet's disease: a systematic review and meta-analysis.抗肿瘤坏死因子治疗英夫利昔单抗治疗神经白塞病的疗效:系统评价和荟萃分析。
J Int Med Res. 2023 May;51(5):3000605231169895. doi: 10.1177/03000605231169895.
3
Cerebral venous thrombosis in adolescence: Looking beyond the obvious.
青少年脑静脉血栓形成:突破表象探寻真相。
Int J Pediatr Adolesc Med. 2022 Dec;9(4):186-189. doi: 10.1016/j.ijpam.2022.09.001. Epub 2022 Sep 29.
4
Improvement of neurological and ocular symptoms of Behçet's disease after the introduction of infliximab.英夫利昔单抗治疗后改善白塞病的神经和眼部症状。
Rheumatol Int. 2018 Jul;38(7):1301-1306. doi: 10.1007/s00296-018-4054-9. Epub 2018 May 17.
5
Infliximab is a plausible alternative for neurologic complications of Behçet disease.英夫利昔单抗是白塞病神经系统并发症的一种合理选择。
Neurol Neuroimmunol Neuroinflamm. 2016 Jul 8;3(5):e258. doi: 10.1212/NXI.0000000000000258. eCollection 2016 Oct.
6
Behçet's Disease and Nervous System Involvement.白塞病与神经系统受累
Curr Treat Options Neurol. 2016 May;18(5):19. doi: 10.1007/s11940-016-0405-6.
7
[Off-label use of infliximab].[英夫利昔单抗的超说明书用药]
Hautarzt. 2013 Oct;64(10):757-61. doi: 10.1007/s00105-013-2596-z.